Prime Therapeutics Newsroom


Prime Therapeutics earns URAC accreditation in pharmacy benefit management

By achieving this status, Prime has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes. More about Prime's accreditation


News from Prime

Final FDA guidance is progress toward biosimilar access, competition

Once a biosimilar is designated as interchangeable, pharmacists may be able to automatically substitute the biosimilar for the reference brand — which should increase their utilization and may save health plans and their members money.

It’s number one, and that’s not a good thing

May is Arthritis Awareness month. Arthritis is the leading cause of disability in the United States and there are a few things you’ll want to know.

Jarrod Henshaw joins Prime Therapeutics as senior vice president, chief supply chain and industry relations officer

Henshaw will set the vision and provide strategic oversight for trade relations with pharmaceutical manufacturers, network management, pharmacy audit, and fraud, waste and abuse (FWA). 















Prime Insights

Explore drug research, analyses and insights from Prime's pharmacy experts.

Prime Insights

Get in touch

Connect with one of our media experts to learn more about the latest news and trends in the pharmacy benefit management industry.

Email the newsroom team
Sign-up for regular email updates